Unknown

Dataset Information

0

Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B.


ABSTRACT: Immunogenicity of vaccines against meningococcal serogroup B (MenB) has been assessed pre-licensure with a human serum bactericidal activity assay (hSBA), tested against small numbers of strains. We report the qualification/validation of an alternative qualitative hSBA which uses endogenous complement (enc-hSBA) present in the vaccinee's serum. Serum samples were collected from adults pre-vaccination and post-vaccination with the 4-component MenB vaccine (4CMenB). A representative panel of invasive isolates and 4 antigen-specific indicator strains were used in qualification experiments. Each strain was tested in ?3 experiments with pre/post-vaccination sera to evaluate intermediate precision. A 110-strain panel and the 4 indicator strains met qualification criteria, demonstrating assay precision. Assay robustness, specificity and sensitivity were demonstrated using the 4 indicator strains. Enc-hSBA is highly standardized, allows testing across large panels of epidemiologically-relevant MenB strains, and accounts for complement activity differences between vaccinees. Therefore, enc-hSBA enables a more accurate estimation of effectiveness for vaccines against MenB.

SUBMITTER: Kleinschmidt A 

PROVIDER: S-EPMC7902841 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B.

Kleinschmidt Annett A   Vadivelu Kumaran K   Serino Laura L   Neidig Nina N   de Wergifosse Bertrand B  

NPJ vaccines 20210223 1


Immunogenicity of vaccines against meningococcal serogroup B (MenB) has been assessed pre-licensure with a human serum bactericidal activity assay (hSBA), tested against small numbers of strains. We report the qualification/validation of an alternative qualitative hSBA which uses endogenous complement (enc-hSBA) present in the vaccinee's serum. Serum samples were collected from adults pre-vaccination and post-vaccination with the 4-component MenB vaccine (4CMenB). A representative panel of invas  ...[more]

Similar Datasets

| S-EPMC5407127 | biostudies-literature
| S-EPMC4733268 | biostudies-literature
| S-EPMC7954916 | biostudies-literature
| S-EPMC4018891 | biostudies-other
| S-EPMC5850644 | biostudies-literature
| S-EPMC5560085 | biostudies-literature
| S-EPMC96111 | biostudies-literature
| S-EPMC3669019 | biostudies-other
| S-EPMC9258937 | biostudies-literature
| S-EPMC108586 | biostudies-literature